Effect of 3 Years of Exercise on Development of Atrial Fibrillation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01680302|
Recruitment Status : Active, not recruiting
First Posted : September 7, 2012
Last Update Posted : February 11, 2019
|Condition or disease||Intervention/treatment||Phase|
|Atrial Fibrillation||Behavioral: High intensity exercise Behavioral: Moderate intensity exercise Behavioral: Control||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||4000 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Effect of 3 Years of Exercise on Development of Atrial Fibrillation - A "Generation 100" Substudy|
|Actual Study Start Date :||September 2012|
|Estimated Primary Completion Date :||December 2022|
|Estimated Study Completion Date :||December 2025|
Experimental: High intensity exercise
High intensity exercise(Borg 16) in intervals.
Behavioral: High intensity exercise
Experimental: Moderate intensity exercise
Moderate intensity exercise 3 times a week.
Behavioral: Moderate intensity exercise
Experimental: Control group
Exercise on their own. Follow current guidelines.
Advised to follow current guidelines for physical activity, but exercise on their own.
- Number of persons who develop atrial fibrillation during the 3 year intervention period [ Time Frame: 3 years ]People who already have the diagnosis before randomisation will not be counted.
- Number of persons who develop atrial fibrillation during the 6 years after randomisation [ Time Frame: 6 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01680302
|Norwegian University of Science and Technology|
|Trondheim, Norway, 7491|
|Study Chair:||Jan Paal Loennechen, PhD||St. Olavs Hospital|